Pre-order Enquiry
Request Free Sample
Global Periodontal Therapeutics Market 2019-2023
SKU ID : TNV-14326678 | Publishing Date : 03-Jun-2019 | No. of pages : 123
Request Sample
Request Customization
Check Discounts
About this Market
Periodontal diseases are prevalent in both developed and developing countries across the world. The disease affects individuals regardless of their age and has become one of the growing public health concerns. The disease is common among individuals in developing countries compared to developed countries. Globally, it is posing as one of the most common oral conditions in human being. The rising prevalence of periodontal diseases across the world will increase the demand for periodontal drugs and subsequently drive the growth of the global periodontal therapeutics market size at a CAGR of over 6% during the forecast period.
Market Overview
Changing lifestyle
Poor oral hygiene, stress, diabetes, smoking, and other age-related risk factors are some of the negative aspects of a fast-changing lifestyle. These factors increase the probability of the onset of periodontal diseases. This is expected to have a positive impact on the growth of the global periodontal therapeutics market size.
Lack of awareness about disease symptoms and cure
There is a delay in the diagnosis and treatment for periodontal disease due to the lack of awareness about the symptoms associated with periodontal diseases. Despite its high prevalence, only a small proportion of the affected population seek medical treatment. This is expected to hinder the growth of the market during the forecast period.
For the detailed list of factors that will drive and challenge the growth of the periodontal therapeutics market size during 2019-2023, view our report.
Competitive Landscape
The market appears to be moderately concentrated with few players occupying the market share. Companies such as 3M Co. and Bausch Health Companies Inc. have intensified competition. Factors such as the growing prevalence of periodontal diseases and the changing lifestyle of people will provide significant growth opportunities for periodontal therapeutics companies. 3M Co., Bausch Health Companies Inc., Den-Mat Holdings LLC, Kaken Pharmaceuticals Co. Ltd., and Teva Pharmaceutical Industries Ltd. are some of the major companies covered in this report.
Periodontal diseases are prevalent in both developed and developing countries across the world. The disease affects individuals regardless of their age and has become one of the growing public health concerns. The disease is common among individuals in developing countries compared to developed countries. Globally, it is posing as one of the most common oral conditions in human being. The rising prevalence of periodontal diseases across the world will increase the demand for periodontal drugs and subsequently drive the growth of the global periodontal therapeutics market size at a CAGR of over 6% during the forecast period.
Market Overview
Changing lifestyle
Poor oral hygiene, stress, diabetes, smoking, and other age-related risk factors are some of the negative aspects of a fast-changing lifestyle. These factors increase the probability of the onset of periodontal diseases. This is expected to have a positive impact on the growth of the global periodontal therapeutics market size.
Lack of awareness about disease symptoms and cure
There is a delay in the diagnosis and treatment for periodontal disease due to the lack of awareness about the symptoms associated with periodontal diseases. Despite its high prevalence, only a small proportion of the affected population seek medical treatment. This is expected to hinder the growth of the market during the forecast period.
For the detailed list of factors that will drive and challenge the growth of the periodontal therapeutics market size during 2019-2023, view our report.
Competitive Landscape
The market appears to be moderately concentrated with few players occupying the market share. Companies such as 3M Co. and Bausch Health Companies Inc. have intensified competition. Factors such as the growing prevalence of periodontal diseases and the changing lifestyle of people will provide significant growth opportunities for periodontal therapeutics companies. 3M Co., Bausch Health Companies Inc., Den-Mat Holdings LLC, Kaken Pharmaceuticals Co. Ltd., and Teva Pharmaceutical Industries Ltd. are some of the major companies covered in this report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
